Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https://t.co/ssmr4XUiWm
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19).
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2020 – Feb 2024Where it's discussed
-
News539 articles
-
X / Twitter173 posts
-
Blogs34 articles
-
Facebook14 posts
-
Reddit9 posts
-
Bluesky2 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions highlight various reactions to the findings of the research, such as the noted higher viral loads in young children compared to adults, with phrases like '10-fold to 100-fold greater' being frequently cited. The tone ranges from urgency in discussing the repercussions for school openings to critiques of existing policies, demonstrated by comments like 'It is incomprehensible that teachers aren't prioritized.' This choice of language and the overall tone reflect concern and a desire for data-driven decision-making, contributing to the observed high interest and significant perceived impact of the article.
The majority of discussions indicate a supportive stance regarding the findings of the publication.
There is a strong curiosity among participants, with numerous individuals asking questions and seeking clarifications.
Some discussions delve into the methodology and implications of the study, but not all users engage deeply.
Many participants express the belief that the publication has significant implications for public health, especially around policies for schools.
Abstract in brief
- This study looks at how SARS-CoV-2 levels in the nasopharynx vary with age in patients who have mild to moderate COVID-19.
- It analyzes differences in viral load among various age groups to better understand the impact of age on infection severity.
- Findings may help inform treatment strategies and public health policies regarding COVID-19 based on age-specific responses.
Top posts
Most liked on X and BlueskyAge-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/cvf1EexnCP
Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (#COVID19): https://t.co/zUOxJ03og7
6/ Wie von andere Studien bestätigt, scheint das Alter nur einen kleinen Einfluss auf die Viruslast zu haben. [3,4] [3] https://t.co/E2Sc71v22u [4] https://t.co/5Pj1t5bGnG
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/7m3XCz9c16
Link to first study: https://t.co/vZDWR2aVIK [5/6]
All mentions
Age Differences in Nasopharyngeal SARS-CoV-2 Levels Explained
This study looks at how SARS-CoV-2 levels in the nasopharynx vary with age in patients with mild to moderate COVID-19. Understanding these differences can inform treatment strategies and public health policies regarding…
Impact of COVID-19 on Children and School Reopening Considerations
As children are susceptible to SARS-CoV-2 infection, recent data reveal they may release infectious virus more than previously understood. Understanding transmission potential in children is critical for public health…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
@Carlitov23 @WhyTHnot @isabelle_denuit @tristanmf https://t.co/mZFScdkPZy
RT @Karl_Lauterbach: (1) Studienlage zur Ansteckung von/durch Kinder SARS-CoV-2 wird immer klarer. Die neue methodisch hochwertige Studie a…
RT @Karl_Lauterbach: (1) Studienlage zur Ansteckung von/durch Kinder SARS-CoV-2 wird immer klarer. Die neue methodisch hochwertige Studie a…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
@JonathanHannah @carlsmythe @TonyBaduy @ghoppe @anxiety_korma @ShockTraumaRN @LifeAfterWEF @_Tetraplegix @Mr_Magoo5 @chimera414 @Jaytee116James @BreezerGalway @djchicus @getstocked44 @MsTrixter @mpc_xetts @hbthbsar @AndrewLazarus4 @AburrallB @dann58638436 @ericmichael74 @SkepticalMutant @SwaledaleMutton @mcfunny @RKontroIisto @Willard1951 @IainMulady @reacharoundu @jrmy_tu @GenderBreadMann @CaeJak @old_move @tarsins @richykirsh @andylumm @ttroutma @JimeeLiberty @Tarsins1 @PremierImproves @Turrialba27 @FillmoreWhite @doom37455413 @JamesLynchGTC @Amber84280581 @WalterTAllen @Dominos20076133 @FoolanderWorld @FvckYourFear @fadgesniffer "Most children have moderate or high viral loads regardless of age, symptoms or severity of infection." https://t.co/tm9Rk17AJ3 "significantly greater amounts of viral nucleic acid are detected in children younger than 5 years" https://t.co/Kzv8s7pPv7
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
@Gettingreadyto1 @CDCgov @CDCMMWR 1. It's actually lower (85%, https://t.co/eYUZTL2W6C) and that's not counting underlying conditions that may make that even lower. 2. That's not exactly true. Concentration in the nasopharynx (upper throat) is 10-100 times higher in comparison to adults (https://t.co/MCZ3JFfd5h).
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
@Orla_Hegarty Papers are here 1/ https://t.co/e9EfPdObIn
"significantly greater amounts of viral nucleic acid are detected in children younger than 5 years" #covid19aus #auspol #covid19nsw #covid19vic https://t.co/87c42ukvJm
RT @DeeGilhawley: Link to first study: https://t.co/vZDWR2aVIK [5/6]
Link to first study: https://t.co/vZDWR2aVIK [5/6]
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @taylorhealdme: Ok, real talk. Tonight I gave my first live TV interview with @TheLastWord It was an amazing experience and this whole…
The observed differences in median CT values between young children and adults approximate a 10-fold to 100-fold greater amount of SARS-CoV-2 in the upper respiratory tract of young children. https://t.co/E2TYfq5W8d
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
@passoa36 @s0f0nisba @mikehoganmedia @Iloveautumn2 https://t.co/VgNtaeEQmq https://t.co/YXm6Xm5BQP https://t.co/lGe8YEf89H https://t.co/xRKSpvhYhz https://t.co/xRKSpvhYhz https://t.co/uTY2yDmKRk https://t.co/UDWJl5HliE https://t.co/RQPu0NR11X https://t.co/DVXsWc0PCD
@jmohlman @FoxNews https://t.co/1NYUcFicU2
@swapneilparikh @wanderer_jasnah @angie_rasmussen "observed differences in median CT values between young children and adults approximate a 10-fold to 100-fold greater amount of SARS-CoV-2 in the upper respiratory tract of young children" https://t.co/2CcVtQZfa2
@angie_rasmussen "observed differences in median CT values between young children and adults approximate a 10-fold to 100-fold greater amount of SARS-CoV-2 in the upper respiratory tract of young children" https://t.co/2CcVtQZfa2
@VanheckeFilip @BernardPauwels2 @vrtnws Geen enkel ? Niet zo goed belezen in de vakliteratuur ? "Our analyses suggest children younger than 5 years with mild to moderate COVID-19 have high amounts of SARS-CoV-2 viral RNA in their nasopharynx compared with older children and adults." https://t.co/WrnoFUfO0s
@theK3nnyS @AugustoHerrmann @Tom88Farias @peterjordan100 @poavocato Iniciando pelo Pediatrics, Official Journal of the American Academy of Pediatrics https://t.co/eD9z6C0eEK sendo o portal Fiocruz defendido até pelo governo onde não ouve outros questionamentos, tembém pela jama pediatrics https://t.co/PY6i6G7X4s
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
RT @influenzer3: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients…
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/cvf1EexnCP
@ellaella963 @troubletone @superfantastic @naomirwolf @JetBlue Found it. It does not necessarily find what the article says. Though it’s possible. School reopening data doesn’t appear to substantiate, plus with vaccines for adults, not sure how my opposition to masks on 3 year olds is objectionable. https://t.co/0uy69OE2UD
RT @skepteis: 6/ Wie von andere Studien bestätigt, scheint das Alter nur einen kleinen Einfluss auf die Viruslast zu haben. [3,4] [3] http…
6/ Wie von andere Studien bestätigt, scheint das Alter nur einen kleinen Einfluss auf die Viruslast zu haben. [3,4] [3] https://t.co/E2Sc71v22u [4] https://t.co/5Pj1t5bGnG
@RainbowLinkInc 幼児は年長の子供や成人と比較して上気道にSARS-CoV-2を約 10 倍から 100 倍多く持っているそうだ(https://t.co/C1Hiy0nc1c)。去年の7月の論文。2020年7月30日。
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
@10secondRunOff @EcoGreenGP @JamesMelville You don't have to trust me, but you really ought to trust the data. Here's the paper from The Journal of the American Medical Association where I got this information. https://t.co/q3LCT4zjzJ
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
RT @Locuste_: Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https:/…
Pour enfoncer le clou, je rappelle que les enfants sont contagieux, quoi qu'aient pu dire ces charlatans de la SPF : https://t.co/ssmr4XUiWm
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
RT @realreporter: @DrZoeHyde Similarly a Chicago hospital study showed the youngest had ten-fold to 100-fold viral loads in upper respirato…
@DrZoeHyde Similarly a Chicago hospital study showed the youngest had ten-fold to 100-fold viral loads in upper respiratory tract. That study was one of the first last year on this issue. Look it up @DGBassani https://t.co/jOo2lWIzpN
RT @mzelst: "Als het een belangrijk effect heeft, sta ik er voor open, maar we weten eigenlijk al dat kinderen op de lagere school in elk g…
RT @mzelst: "Als het een belangrijk effect heeft, sta ik er voor open, maar we weten eigenlijk al dat kinderen op de lagere school in elk g…
@CailletGrgoire @arnaud_fourel Voici les études scientifiques fournies à l'époque : [1] https://t.co/pUTwCEsFgp [2] https://t.co/cdC0AJpGoH [3] https://t.co/UQbqoDDsIa [4] https://t.co/C8xbzAAcS8 [5] https://t.co/tvPJn7dWqa [6] https://t.co/5AXqqgok6e [7] https://t.co/76xfrmcjtD
@dai_jiro Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/b3moyisfQ0
@GuarraChina @verolinerock Respuesta 4 https://t.co/4pocWpYE2s
@DrTomrisCesur @ncholiA https://t.co/QQ4xG8hCGt Sn. @DrTomrisCesur , bu yayında 5 yaş altındaki çocukların da çok bulaştırıcı olduğu gösterilmiş; sizin paylaştığınız dokümandaki bilginin aksine. Sizin kadar doğru yorumlayamayabilirim. Ama bunlar tedirgin edici gerçekler.
@takibidoc Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/b3moyisfQ0
@MIHO75232025 @renren_pien Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/b3moyisfQ0
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/b3moyiJQHy
RT @canchemistry: 別の研究では「5歳未満の軽症患者(≠無症状)の、ウイルスRNA検出量(≠放出量)は、大人の患者の10~100倍以上多い」ことが分かっています(↓)。 このように、「白血病による免疫不全患者」と「獲得免疫が未成熟な小児」には、COVIDに対して…
@Redkiraz @silviast9 @dgurdasani1 @DrZoeHyde @devisridhar @kprather88 @nicolamlow @AllamanSeb @eggersnsf @FLAHAULT @EckerleIsabella @C_Althaus @watson_news @Blickch @OMPWashington Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/b3moyiJQHy
@lachattenoire78 @sosorasora3 Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/b3moyiJQHy
@Gary_Kidson @dr_muniyappa @devisridhar Here's the study from Iceland. It's small but it looks like kids have a lower Ct (talking about patient Ct not test Ct), but this doesn't speak to spread. It just means that kids touch more stuff God bless 'em!https://t.co/wPwQ7fTVo9
11) For more on some studies that find high [similarity in] viral load in children vs. adults, read here (Swedish: https://t.co/H7QUQB5IAz), or e.g. these studies: https://t.co/z7Jvrn5bvy, https://t.co/7GcFqx0z73.
@Medical_News_J Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/b3moyiJQHy
RT @G_innovates: @crowmogh It is incomprehensible that teachers aren't prioritized (for vaccine) when everyone is talking about why we must…
@crowmogh It is incomprehensible that teachers aren't prioritized (for vaccine) when everyone is talking about why we must send kids back to school urgently. Younger kids have a high viral load (fact). When unmasked, the risk of transmission is significant. #COVID19 https://t.co/GTMpn7bcx8
@sarahlbyer @harryd20200 @LBC https://t.co/TMBy0MKmvc
RT @ygjumi: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With…
RT @ygjumi: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With…
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/AgmeeHom9P
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/VcEokCina6
RT @ygjumi: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With…
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/5dnOCQOHaz
@morningshow_tv Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/b3moyiJQHy
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/TF0D3KXcnw
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) -- July 2020 -- https://t.co/12PlJpxqeg
RT @MerciePatrick: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patient…
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/X9n13x1m80
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/Kvd2RJHvxt
再掲 Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/XjZ2KO0z28
@Merg_The_One @delosquesobran Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) Heald-Sargent et al, 30 July 2020 doi:10.1001/jamapediatrics.2020.3651
Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (#COVID19): https://t.co/zUOxJ03og7
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/Y3f5xHk9sV
@jasoncbrady @buckeyemom12 @dwcrooks @11W Jason, thanks for your eloquent response. I expect more from a "chemist". Tell the JAMA Peddiatr authors july 30 2020 - Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 your critique of their RESEARCH, not pontification. READ.
Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (#COVID19): https://t.co/zUOxJ03og7
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/c00yHtkwb4
RT @merjah: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With…
RT @merjah: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With…
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics #koronalapset #koronavirus https://t.co/tENtlor2DH
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/NmMJBWP1OB
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/3m1TKnGG4Z
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/mqOwzrATfV
5歳以下の小児はSARS-CoV2の上気道からの排泄量は成人の10倍〜100倍 https://t.co/mgBXB3l3tl
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/uX1A1FSe3B
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network @mignoloeprof https://t.co/ZB4ElnGWoI
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/ddDG2b069O
@Farnarkelist @vanOnselenP https://t.co/Gnz3g700Gv
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/5BbBbatets
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/uOj4agmMkq
I am curious what others think about this: https://t.co/oHkLNyV8vO "... replication of SARS-CoV-2 in older children leads to similar levels of viral nucleic acid as adults, but significantly greater amounts of viral nucleic acid are detected in children younger than 5 years." (1/
People are going to die. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 https://t.co/T90t8GPgC1 @JAMANetwork @taylorhealdme #pandemicpods #safeschoolsnow
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/klmpkkMVjV https://t.co/aRyaFAAtwc
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/0VOMPmgp8M
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/A1QuwveQ9u
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2768952
@dougducey Young children carry 10-100 times the virus load as adults - still want to start school Aug 17? Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients| JAMA Network https://t.co/BZ8dYCBZWo
free, online Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/TkJZEUaI4r https://t.co/LXAfTn81iD
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/P07IKbTWN9
“Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network“ https://t.co/CkWPp3MJTo
RT @MicroUFMG: #COVID19: Por que não é o momento de reabrir escolas? Crianças podem transmitir tanto quanto adultos! #Novidades 》Veja o re…
#COVID19: Por que não é o momento de reabrir escolas? Crianças podem transmitir tanto quanto adultos! #Novidades 》Veja o resto do vídeo em nosso canal do YouTube: https://t.co/n1wWqem13u #SARSCoV2 #transmissão #coronavirus #vírus #MicroUFMG #nósUFMG #FiqueEmCasa https://t.co/EBGIW1LN42
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/LrnbkNk9aT
@business @QuickTake That's the perceive "wisdom" but mounting evidence suggests we may be wrong doi:10.1001/jamapediatrics.2020.3651 https://t.co/H88cos9WBN
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/FDYAOD5BGC
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/W2LQsqrgwx
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/7m3XCz9c16
So, Do we want to open schools coming soon? Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients (#Covid_19 | JAMA https://t.co/7Sg0F40VhA
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/EWxmC2cIpo
Young children are infectious, in Chicago study. #covid19 Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19)JAMA Pediatrics https://t.co/qYWJ0i6tsM
A study comparing the level of COVID-19 virus RNA in children under five with other age groups found young children under five had higher numbers of viral RNA than older children and adults. See: JAMA Pediatr. Published online July 30, 2020. doi:10.1001/jamapediatrics.2020.3651
Children as SARS-CoV2 spreaders reported in two recent papers. (1) children <5y old have more viral RNA in upper respiratory tract compared with older children and adults. JAMA Pediatrics <doi:10.1001/jamapediatrics.2020.3651> https://t.co/2vW0WTEiBG
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/PAIh8C2ZDV
RT @worldallergy: Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels…
RT @Aller_MD: Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in P…
RT @worldallergy: Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels…
RT @Aller_MD: Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in P…
RT @worldallergy: Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels…
RT @Aller_MD: Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in P…
RT @Aller_MD: Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in P…
RT @worldallergy: Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels…
RT @worldallergy: Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels…
RT @uchida_kawasaki: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patie…
RT @CassanoraL: Published today: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Le…
Published today: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/qABI0egrFf
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/QhSPz1G5rA
RT @dho: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mil…
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/EcaNYZbvsV
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) https://t.co/zpaV7xMqMT
Important study to consider with school reopening: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) JAMA Paediatrics&Network https://t.co/lWWTwpuPk0
@BetsyDeVosED @VP @Mike_Pence @Thales_Academy Please read "Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19)" https://t.co/PBpbvPLwM7
Top story: Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA… https://t.co/J9fQvsrOob, see more https://t.co/yY235U3AWr
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/046xaROIPh
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19) | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/C8KBjSKA0K https://t.co/ivciu8KUfl
geral" https://jamanetwork.com/journals/jamapediatrics/fullarticle/2768952?resultClick=1